Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Unusual Machines heads into the final stretch of summer with a contradictory setup: short sellers are quietly reducing exposure, yet the borrow market has tightened sharply in just one week. Short interest has drifted…
IBIT gives back ground this week — down 2.1% to $43.76 — as two signals that looked constructive heading into September have quietly turned in the other direction: short interest ticked higher for the first time in…
Bitdeer Technologies Group has given back most of the gains that briefly rattled the bears last week, dropping 8.3% over the past five days to $10.35 — and the short position that shrugged off that rally has barely…
Fortrea Holdings enters September with an unusual split: analysts lifted targets after the last earnings print, yet shorts have quietly rebuilt to their highest level in months while options traders have swung from…
Disc Medicine enters September with a fresh analyst upgrade pulling in one direction and options traders turning more defensive than they've been in weeks — an unusual split for a biotech that has barely moved on the…
OABI enters September at a fragile junction — a stock that nearly doubled in a month now faces growing short-side pressure and a cost-to-borrow spike, even as the analyst consensus remains firmly bullish. The most…
DSGR enters September with one story dominating everything else: a live go-private offer that has set a hard floor under the stock while shorts quietly exit. Luther King Capital Management Corporation — already the…
Warner Bros. Discovery enters September with an unusual split in its positioning data: options traders are pushing put demand to elevated levels at the same time short sellers are aggressively reducing exposure,…
SoundHound AI ends the week in the same structural bind that has defined it all month — 41% short, zero availability, and a borrow market that has now been completely exhausted for over five consecutive weeks without a…
PWRD, the TCW Transform Systems ETF, heads into September with borrowed shares more than doubling in a single week — an unusual move for an ETF that rarely generates this kind of lending market activity. The short…
Credo Technology Group enters the post-earnings session with a sharp reset: the stock fell 8.6% on September 1, extending a near-identical weekly decline, as fiscal Q1 results landed and the Street immediately moved to…
TeraWulf is caught in a painful squeeze between a stock down 17% on the month, shorts that show no sign of covering, and executives who sold millions of dollars of shares on the way down. The insider activity is the…
BRZE enters its September 8 earnings print in an unusual bind: the stock is up 32% over the past month, analysts are rushing to lift targets, yet short sellers have quietly rebuilt a meaningful position in the…
IREN enters September with bears fully re-entrenched after the earnings disappointment, the borrow pool at its tightest in a year, and analysts holding price targets that imply more than double the current price — a…
Nuvectis Pharma heads into September with its short book quietly unwinding and the lending market loosening at the fastest pace of the year — a notable shift from the elevated positioning that defined August. The…
Crescent Energy heads into September with short sellers beating a significant retreat — and the Street split on whether the rally has further to run. The most striking data point this week is the pace of short…
GLOBALFOUNDRIES enters September under pressure, down 12% over the past month to $43.93, as fresh analyst coverage lands well below consensus and options market participants have turned markedly more defensive. The…
GTLB has cleared its earnings hurdle and the market is now digesting the aftermath — a stock down 3% on the day after results, yet still up 8% on the week, with analysts scrambling to re-anchor targets above where they…
SRAD enters September with a sharp divergence between analyst conviction and market positioning — a $22 Wolfe Research target arriving just as the stock trades at $12.31, down 15% over the past month and 4.6% on the…
DUOL is up 9% on the week and nearly 18% over the past month — but with 17.6% of the free float still sold short and the Street deeply divided on whether the stock has genuinely turned, this rally arrives with a…
